Cannabis Watch: HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

The DEA is not bound to follow the U.S. Health and Human Services Department’s recommendation to reclassify marijuana as a Schedule III drug.

Previous post The Margin: Taylor Swift’s ‘Eras Tour’ is coming to movie theaters for under $20 a ticket
Next post Economic Report: Chicago business activity index rises in August to highest reading for past year